{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:07:55Z","timestamp":1790042875476,"version":"4.0.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.ejmech.2023.116116","type":"journal-article","created":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T03:04:08Z","timestamp":1704510248000},"page":"116116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Novel berberine derivatives as p300 histone acetyltransferase inhibitors in combination treatment for breast cancer"],"prefix":"10.1016","volume":"266","author":[{"given":"Ruizhi","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqian","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Hai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongzhen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruifang","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0719-4963","authenticated-orcid":false,"given":"Yong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2023.116116_bib1","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1021\/cr500452k","article-title":"Protein lysine acetylation by p300\/CBP","volume":"115","author":"Dancy","year":"2015","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2023.116116_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112861","article-title":"Current development of CBP\/p300 inhibitors in the last decade","volume":"209","author":"He","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.116116_bib3","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3390\/biom13030417","article-title":"Effects of the acetyltransferase p300 on tumour regulation from the novel perspective of posttranslational protein modification","volume":"13","author":"Zeng","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejmech.2023.116116_bib4","doi-asserted-by":"crossref","first-page":"8123","DOI":"10.1128\/MCB.19.12.8123","article-title":"Biochemical analysis of distinct activation functions in p300 that enhance transcription initiation with chromatin templates","volume":"19","author":"Kraus","year":"1999","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2023.116116_bib5","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1038\/sj.onc.1204329","article-title":"Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription","volume":"20","author":"Dilworth","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2023.116116_bib6","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.3390\/cancers13112799","article-title":"Pharmacological inhibition of CBP\/p300 blocks estrogen receptor alpha (ER\u03b1) function through suppressing enhancer H3K27 acetylation in luminal breast cancer","volume":"13","author":"Waddell","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ejmech.2023.116116_bib7","doi-asserted-by":"crossref","first-page":"4716","DOI":"10.1021\/acs.jmedchem.9b02164","article-title":"Discovery, structure-activity relationship, and biological activity of histone-competitive inhibitors of histone acetyltransferases P300\/CBP","volume":"63","author":"Wu","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.116116_bib8","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1097-2765(00)80452-9","article-title":"HATs off: selective synthetic inhibitors of the histone acetyltransferases p300 and PCAF","volume":"5","author":"Lau","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejmech.2023.116116_bib9","doi-asserted-by":"crossref","first-page":"19134","DOI":"10.1074\/jbc.M301580200","article-title":"Small molecule modulators of histone acetyltransferase p300","volume":"278","author":"Balasubramanyam","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2023.116116_bib10","doi-asserted-by":"crossref","first-page":"51163","DOI":"10.1074\/jbc.M409024200","article-title":"Curcumin, a novel p300\/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone\/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription","volume":"279","author":"Balasubramanyam","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2023.116116_bib11","doi-asserted-by":"crossref","first-page":"33716","DOI":"10.1074\/jbc.M402839200","article-title":"Polyisoprenylated benzophenone, garcinol, a natural histone acetyltransferase inhibitor, represses chromatin transcription and alters global gene expression","volume":"279","author":"Balasubramanyam","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2023.116116_bib12","doi-asserted-by":"crossref","first-page":"61137","DOI":"10.1039\/C6RA11240D","article-title":"Identification of new p300 histone acetyltransferase inhibitors from natural products by a customized virtual screening method","volume":"6","author":"Li","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2023.116116_bib13","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1039\/C4MD00245H","article-title":"Pyrido- and benzisothiazolones as inhibitors of histone acetyltransferases (HATs)","volume":"5","author":"Furdas","year":"2014","journal-title":"Med. Chem. Comm"},{"key":"10.1016\/j.ejmech.2023.116116_bib14","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.bmc.2014.01.022","article-title":"Synthesis of a novel series of thiazole-based histone acetyltransferase inhibitors","volume":"22","author":"Secci","year":"2014","journal-title":"Biorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.116116_bib15","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.1016\/j.bmc.2018.07.048","article-title":"Discovery and biological evaluation of thiobarbituric derivatives as potent p300\/CBP inhibitors","volume":"26","author":"Lu","year":"2018","journal-title":"Biorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.116116_bib16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejmech.2019.07.026","article-title":"Design, synthesis, and biological evaluation of a new class of histone acetyltransferase p300 inhibitors","volume":"180","author":"Liu","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.116116_bib17","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1021\/acs.jmedchem.2c01641","article-title":"Discovery of DS-9300: a highly potent, selective, and once-daily oral EP300\/CBP histone acetyltransferase inhibitor","volume":"66","author":"Kanada","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.116116_bib18","doi-asserted-by":"crossref","first-page":"14391","DOI":"10.1021\/acs.jmedchem.2c00670","article-title":"Discovery of proline-based p300\/CBP inhibitors using DNA-encoded library Technology in combination with high-throughput screening","volume":"65","author":"Tian","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.116116_bib19","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.chembiol.2010.03.006","article-title":"Virtual ligand screening of the p300\/CBP histone acetyltransferase: identification of a selective small molecule inhibitor","volume":"17","author":"Bowers","year":"2010","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2023.116116_bib20","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nature24028","article-title":"Discovery of a selective catalytic p300\/CBP inhibitor that targets lineage-specific tumours","volume":"550","author":"Lasko","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2023.116116_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/toxins12110713","article-title":"Biological activity of berberine-A summary update","volume":"12","author":"Och","year":"2020","journal-title":"Toxins"},{"key":"10.1016\/j.ejmech.2023.116116_bib22","first-page":"226","article-title":"Plant isoquinoline alkaloids: advances in the chemistry and biology of berberine","author":"Singh","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.116116_bib23","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s11684-019-0724-6","article-title":"Biological properties and clinical applications of berberine","volume":"14","author":"Song","year":"2020","journal-title":"Front Med-Prc"},{"key":"10.1016\/j.ejmech.2023.116116_bib24","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/ejoc.201701693","article-title":"Total synthesis and evaluation of B-Homo palmatine and berberine derivatives as p300 histone acetyltransferase inhibitors","author":"Yang","year":"2018","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.ejmech.2023.116116_bib25","first-page":"138","article-title":"Discovery of berberine analogs as potent and highly selective p300\/CBP HAT inhibitors","author":"Zhong","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2023.116116_bib26","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1182\/bloodadvances.2020001879","article-title":"Antitumor activity of the dual BET and CBP\/EP300 inhibitor NEO2734","volume":"4","author":"Spriano","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.ejmech.2023.116116_bib27","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1021\/acs.biochem.9b00160","article-title":"Combination targeting of the bromodomain and acetyltransferase active site of p300\/CBP","volume":"58","author":"Zucconi","year":"2019","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2023.116116_bib28","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000610","article-title":"The novel oral BET-CBP\/p300 dual inhibitor NEO2734 is highly effective in eradicating acute myeloid leukemia blasts and stem\/progenitor cells","volume":"5","author":"van Gils","year":"2021","journal-title":"Hemasphere"},{"key":"10.1016\/j.ejmech.2023.116116_bib29","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1038\/s41388-020-1270-z","article-title":"p300\/CBP inhibition enhances the efficacy of programmed death-ligand 1 blockade treatment in prostate cancer","volume":"39","author":"Liu","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2023.116116_bib30","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abf0992","article-title":"TRIB3 reduces CD8+ T cell infiltration and induces immune evasion by repressing the STAT1-CXCL10 axis in colorectal cancer","volume":"14","author":"Shang","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejmech.2023.116116_bib31","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1080\/01635581.2015.1085581","article-title":"Berberine and curcumin target survivin and STAT3 in gastric cancer cells and synergize actions of standard chemotherapeutic 5-fluorouracil","volume":"67","author":"Pandey","year":"2015","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.ejmech.2023.116116_bib32","doi-asserted-by":"crossref","first-page":"76385","DOI":"10.18632\/oncotarget.20059","article-title":"Berberine and cinnamaldehyde together prevent lung carcinogenesis","volume":"8","author":"Meng","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2023.116116_bib33","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1142\/S0192415X15500846","article-title":"Berberine increases doxorubicin sensitivity by suppressing STAT3 in lung cancer","volume":"43","author":"Zhu","year":"2015","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.ejmech.2023.116116_bib34","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3892\/or.2016.4785","article-title":"Berberine in combination with cisplatin suppresses breast cancer cell growth through induction of DNA breaks and caspase-3-dependent apoptosis","volume":"36","author":"Zhao","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ejmech.2023.116116_bib35","first-page":"6141","article-title":"Berberine and evodiamine act synergistically against human breast cancer MCF-7 cells by inducing cell cycle arrest and apoptosis","volume":"37","author":"Du","year":"2017","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ejmech.2023.116116_bib36","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.3892\/mmr.2016.5490","article-title":"Berberine enhances the anti-tumor activity of tamoxifen in drug-sensitive MCF-7 and drug-resistant MCF-7\/TAM cells","volume":"14","author":"Wen","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejmech.2023.116116_bib37","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejps.2007.02.001","article-title":"Permeation of permanently positive charged molecules through artificial membranes - influence of physico-chemical properties","volume":"31","author":"Fischer","year":"2007","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2023.116116_bib38","article-title":"Cobalt-mediated decarboxylative\/desilylative C-H activation\/annulation reaction: an efficient approach to natural alkaloids and new structural analogues","author":"Chen","year":"2022","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.ejmech.2023.116116_bib39","doi-asserted-by":"crossref","first-page":"11418","DOI":"10.1039\/C9CC05804D","article-title":"Water-mediated C-H activation of arenes with secure carbene precursors: the reaction and its application","volume":"55","author":"Nie","year":"2019","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2023.116116_bib40","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1021\/bi500380f","article-title":"Structure of the p300 histone acetyltransferase bound to acetyl-coenzyme A and its analogues","volume":"53","author":"Maksimoska","year":"2014","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2023.116116_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113914","article-title":"A novel histone acetyltransferase inhibitor A485 improves sensitivity of non-small-cell lung carcinoma cells to TRAIL","volume":"175","author":"Zhang","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2023.116116_bib42","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the chou-talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2023.116116_bib43","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1432-1033.1981.tb06218.x","article-title":"Generalized equations for the analysis of inhibitions of michaelis-menten and higher-order kinetic systems with 2 or more mutually exclusive and non-exclusive inhibitors","volume":"115","author":"Chou","year":"1981","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ejmech.2023.116116_bib44","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative-analysis of dose-effect relationships - the combined effects of multiple-drugs or enzyme-inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv. Enzym. Regul."},{"key":"10.1016\/j.ejmech.2023.116116_bib45","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/emboj.2010.318","article-title":"Distinct roles of GCN5\/PCAF-mediated H3K9ac and CBP\/p300-mediated H3K18\/27ac in nuclear receptor transactivation","volume":"30","author":"Jin","year":"2011","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmech.2023.116116_bib46","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.biopha.2015.03.009","article-title":"Lapatinib enhances the cytotoxic effects of doxorubicin in MCF-7 tumorspheres by inhibiting the drug efflux function of ABC transporters","volume":"72","author":"Chun","year":"2015","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2023.116116_bib47","article-title":"Autophagy and multidrug resistance in cancer","volume":"52","author":"Li","year":"2017","journal-title":"Chin. J. Cancer"},{"key":"10.1016\/j.ejmech.2023.116116_bib48","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-42357-w","article-title":"Metformin prevention of doxorubicin resistance in MCF-7 and MDA-MB-231 involves oxidative stress generation and modulation of cell adaptation genes","volume":"9","author":"Marinello","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2023.116116_bib49","first-page":"75","article-title":"PARP inhibitor re-sensitizes Adriamycin resistant leukemia cells through DNA damage and apoptosis","volume":"19","author":"Wu","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejmech.2023.116116_bib50","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.3892\/etm.2017.4763","article-title":"Attenuation of doxorubicin-induced cardiotoxicity by esculetin through modulation of Bmi-1 expression","volume":"14","author":"Xu","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ejmech.2023.116116_bib51","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/sj.embor.embor821","article-title":"Stimulation of c-MYC transcriptional activity and acetylation by recruitment of the cofactor CBP","volume":"4","author":"Vervoorts","year":"2003","journal-title":"EMBO Rep."},{"key":"10.1016\/j.ejmech.2023.116116_bib52","doi-asserted-by":"crossref","DOI":"10.1186\/s13072-018-0197-x","article-title":"CREBBP\/EP300 bromodomains are critical to sustain the GATA1\/MYC regulatory axis in proliferation","volume":"11","author":"Garcia-Carpizo","year":"2018","journal-title":"Epigenet. Chromatin"},{"key":"10.1016\/j.ejmech.2023.116116_bib53","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1158\/2159-8290.CD-15-0754","article-title":"Targeting p300 addiction in CBP-deficient cancers causes synthetic lethality by apoptotic cell death due to abrogation of expression","volume":"6","author":"Ogiwara","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ejmech.2023.116116_bib54","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3892\/ijo.2015.3288","article-title":"Epigenetic regulation of proliferation and invasion in hepatocellular carcinoma cells by CBP\/p300 histone acetyltransferase activity","volume":"48","author":"Inagaki","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejmech.2023.116116_bib55","doi-asserted-by":"crossref","first-page":"10035","DOI":"10.1021\/acs.joc.0c01283","article-title":"Total synthesis of (+\/-)-Clivonine via diels-alder reactions of 3,5-Dibromo-2-pyrone","volume":"85","author":"Wang","year":"2020","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2023.116116_bib56","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/adsc.201701508","article-title":"Chelation-promoted efficient C-H\/N-H cross dehydrogenative coupling between picolinamides and simple ethers under copper catalysis","volume":"360","author":"Yue","year":"2018","journal-title":"Adv. Synth. Catal."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423010838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423010838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T02:15:22Z","timestamp":1722910522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523423010838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":56,"alternative-id":["S0223523423010838"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.116116","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel berberine derivatives as p300 histone acetyltransferase inhibitors in combination treatment for breast cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.116116","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116116"}}